Seòmar agus comataidhean

Questions and answers

Parliamentary questions can be asked by any MSP to the Scottish Government or the Scottish Parliamentary Corporate Body. The questions provide a means for MSPs to get factual and statistical information.

Written questions must be answered within 10 working days (20 working days during recess)
Other questions such as Topical, Portfolio, General and First Minister's Question Times are taken in the Chamber

Urgent Questions aren't included in the Question and Answers search. There is a SPICe fact sheet listing Urgent and emergency questions.

Find out more about parliamentary questions

Criathragan Hide all filters

Displaying 47060 questions Show Answers

Order by |

Question reference: S6O-02001

Asked by: Brian Whittle, MSP for South Scotland, Scottish Conservative and Unionist Party
Date lodged: Wednesday, 08 March 2023
Current Status: Taken in the Chamber on 15 March 2023

To ask the Scottish Government what discussions the rural affairs secretary has had with ministerial colleagues regarding how it will ensure that the needs of the rural economy are considered in its plans for the decarbonisation of transport.

Question reference: S6O-02017

Asked by: Monica Lennon, MSP for Central Scotland, Scottish Labour
Date lodged: Wednesday, 08 March 2023
Current Status: Taken in the Chamber on 16 March 2023

To ask the Scottish Government whether it will provide an update on progress with its Tackling Child Poverty Delivery Plan, including in relation to expanding free school meal provision.

Question reference: S6O-02009

Asked by: Kaukab Stewart, MSP for Glasgow Kelvin, Scottish National Party
Date lodged: Wednesday, 08 March 2023
Current Status: Taken in the Chamber on 15 March 2023

To ask the Scottish Government whether it will provide an update on any ongoing work with NHS Golden Jubilee to make additional capacity available for elective operations in order to minimise pressure on waiting times.

Question reference: S6O-02019

Asked by: Tess White, MSP for North East Scotland, Scottish Conservative and Unionist Party
Date lodged: Wednesday, 08 March 2023
Current Status: Taken in the Chamber on 16 March 2023

To ask the Scottish Government what action it is taking to support local authorities to ensure that the provision of local services, including swimming pools and leisure centres, meets the needs of local communities.

Question reference: S6O-01998

Asked by: Pam Gosal, MSP for West Scotland, Scottish Conservative and Unionist Party
Date lodged: Wednesday, 08 March 2023
Current Status: Taken in the Chamber on 15 March 2023

To ask the Scottish Government whether it will provide an update on when its response to the Agriculture Bill consultation will be published.

Question reference: S6O-02002

Asked by: Clare Adamson, MSP for Motherwell and Wishaw, Scottish National Party
Date lodged: Wednesday, 08 March 2023
Current Status: Taken in the Chamber on 15 March 2023

To ask the Scottish Government what its initial assessment is of the potential impact of the Windsor Framework on the food and drink supply chain in Scotland.

Question reference: S6O-02005

Asked by: Willie Rennie, MSP for North East Fife, Scottish Liberal Democrats
Date lodged: Wednesday, 08 March 2023
Current Status: Taken in the Chamber on 15 March 2023

To ask the Scottish Government whether it will provide an update on the recruitment of breast cancer oncologists in NHS Tayside.

Question reference: S6W-15268

Asked by: Pam Duncan-Glancy, MSP for Glasgow, Scottish Labour
Date lodged: Wednesday, 22 February 2023
Current Status: Answered by Humza Yousaf on 8 March 2023

To ask the Scottish Government what steps it is taking to reduce any regional variation in levels of access to advanced therapies for rheumatoid arthritis.

In Scotland, the Scottish Medicines Consortium (SMC) appraises the clinical and cost-effectiveness of newly-licensed medicines. Following receipt of a submission from the manufacturer, the SMC carries out an appraisal of the medicine and then determines whether it should be accepted for routine use within the NHS in Scotland. The SMC appraisal is undertaken independently of Scottish Ministers and is based on the clinical and cost-effectiveness of the medicine at a population level. Following the appraisal process, the SMC publishes advice for NHS Scotland Health Boards to consider. The decision to prescribe a medicine for a patient, and which medicine to prescribe, is entirely for the clinician in charge of a patient’s care, having taken into account the patient’s clinical condition and any relevant clinical guidance.

To support financial and service planning, the SMC also provides Health Boards – in confidence – information on medicines that may require a companion diagnostic through regular Forward Look reports which include emerging new medicines, including advanced therapy medicinal products (ATMPs).

Question reference: S6W-15267

Asked by: Pam Duncan-Glancy, MSP for Glasgow, Scottish Labour
Date lodged: Wednesday, 22 February 2023
Current Status: Answered by Humza Yousaf on 8 March 2023

To ask the Scottish Government whether it will provide the current average (a) remission rate and (b) waiting time for treatment for rheumatoid arthritis, broken down by NHS board.

Question reference: S6W-15266

Asked by: Pam Duncan-Glancy, MSP for Glasgow, Scottish Labour
Date lodged: Wednesday, 22 February 2023
Current Status: Answered by Humza Yousaf on 8 March 2023

To ask the Scottish Government how it is supporting access to advanced therapies for people with rheumatoid arthritis.

The Scottish Government is committed to ensuring that people living in Scotland with long term conditions such as rheumatoid arthritis are able to access the best possible care and support.

The Scottish Government is working to ensure an overarching approach for advanced therapy medicinal products (ATMPs) is in place in order to facilitate a ‘once for Scotland’ approach, where possible. We recognise that there are wide-ranging implications and challenges for the managed introduction of these personalised medicines, and are committed to adopting a co-ordinated approach where practical. We are working across Government to develop our understanding of the future direction for this area of medicines policy, including associated genomic testing and service planning implications for the NHS.